We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Applied Therapeutics Inc (APLT) USD0.0001

Sell:$0.0932 Buy:$0.0946 Change: $0.0038 (3.95%)
Market closed |  Prices as at close on 27 January 2026 | Switch to live prices |
Takeover

Applied Therapeutics Inc USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 21 Jan 2026)

The boards of Applied Therapeutics Inc and AT2B, INC., an indirect wholly owned subsidiary of Cycle Group Holdings Limited, recently announced the terms of a takeover. Under the terms of the takeover you have been offered USD0.088 and 1 Contingent Value Right (CVR) for each share held.

The CVRs represent the right to receive up to four contingent cash payments of up to an aggregate of USD0.40 per CVR upon the achievement of certain specified milestones plus the pro rata portion of a certain specified closing cash payment. The terms of the CVRs are outlined in the tender offer schedule available at https://ir.appliedtherapeutics.com/financial-information/sec-filings.

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

Accept the offer – Act by noon on Friday 23 January 2026

Any shares you ask to sell will be removed from your portfolio from 23 January 2026. Cash from shares sold will be converted from US Dollars to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees, and credited to your account. Any shares not successfully sold will be returned to your account around the same time.


Full details of this event will be sent to qualifying Hargreaves Lansdown clients by secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$0.0932
Buy:$0.0946
Change: $0.0038 (3.95%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 27 January 2026 | Switch to live prices |
Takeover

Applied Therapeutics Inc USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 21 Jan 2026)

The boards of Applied Therapeutics Inc and AT2B, INC., an indirect wholly owned subsidiary of Cycle Group Holdings Limited, recently announced the terms of a takeover. Under the terms of the takeover you have been offered USD0.088 and 1 Contingent Value Right (CVR) for each share held.

The CVRs represent the right to receive up to four contingent cash payments of up to an aggregate of USD0.40 per CVR upon the achievement of certain specified milestones plus the pro rata portion of a certain specified closing cash payment. The terms of the CVRs are outlined in the tender offer schedule available at https://ir.appliedtherapeutics.com/financial-information/sec-filings.

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

Accept the offer – Act by noon on Friday 23 January 2026

Any shares you ask to sell will be removed from your portfolio from 23 January 2026. Cash from shares sold will be converted from US Dollars to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees, and credited to your account. Any shares not successfully sold will be returned to your account around the same time.


Full details of this event will be sent to qualifying Hargreaves Lansdown clients by secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$0.0932
Buy:$0.0946
Change: $0.0038 (3.95%)
Market closed |  Prices as at close on 27 January 2026 | Switch to live prices |
Takeover

Applied Therapeutics Inc USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 21 Jan 2026)

The boards of Applied Therapeutics Inc and AT2B, INC., an indirect wholly owned subsidiary of Cycle Group Holdings Limited, recently announced the terms of a takeover. Under the terms of the takeover you have been offered USD0.088 and 1 Contingent Value Right (CVR) for each share held.

The CVRs represent the right to receive up to four contingent cash payments of up to an aggregate of USD0.40 per CVR upon the achievement of certain specified milestones plus the pro rata portion of a certain specified closing cash payment. The terms of the CVRs are outlined in the tender offer schedule available at https://ir.appliedtherapeutics.com/financial-information/sec-filings.

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

Accept the offer – Act by noon on Friday 23 January 2026

Any shares you ask to sell will be removed from your portfolio from 23 January 2026. Cash from shares sold will be converted from US Dollars to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees, and credited to your account. Any shares not successfully sold will be returned to your account around the same time.


Full details of this event will be sent to qualifying Hargreaves Lansdown clients by secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

No news items about Applied Therapeutics Inc USD0.0001 were found.

Company announcements Announcements

No company announcements about Applied Therapeutics Inc USD0.0001 were found.


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2026. All rights reserved.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.